These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

681 related articles for article (PubMed ID: 34585944)

  • 1. Antimicrobial Resistance and Type III Secretion System Virulotypes of Pseudomonas aeruginosa Isolates from Dogs and Cats in Primary Veterinary Hospitals in Japan: Identification of the International High-Risk Clone Sequence Type 235.
    Hayashi W; Izumi K; Yoshida S; Takizawa S; Sakaguchi K; Iyori K; Minoshima KI; Takano S; Kitagawa M; Nagano Y; Nagano N
    Microbiol Spectr; 2021 Oct; 9(2):e0040821. PubMed ID: 34585944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution of sequence types and antimicrobial resistance of clinical Pseudomonas aeruginosa isolates from dogs and cats visiting a veterinary teaching hospital in Thailand.
    Jangsangthong A; Lugsomya K; Apiratwarrasakul S; Phumthanakorn N
    BMC Vet Res; 2024 May; 20(1):234. PubMed ID: 38822333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An outbreak of fluoroquinolone-resistant Pseudomonas aeruginosa ST357 harboring the exoU gene.
    Kainuma A; Momiyama K; Kimura T; Akiyama K; Inoue K; Naito Y; Kinoshita M; Shimizu M; Kato H; Shime N; Fujita N; Sawa T
    J Infect Chemother; 2018 Aug; 24(8):615-622. PubMed ID: 29628388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secondary in-hospital epidemiological investigation after an outbreak of Pseudomonas aeruginosa ST357.
    Mihara T; Kimura T; Momiyama K; Kainuma A; Akiyama K; Ohara J; Inoue K; Kinoshita M; Shimizu M; Moriyama K; Fujita N; Sawa T
    J Infect Chemother; 2020 Mar; 26(3):257-265. PubMed ID: 31680038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial Resistance of Pseudomonas aeruginosa Isolated from Dogs and Cats in Primary Veterinary Hospitals in Japan.
    Yukawa S; Tsuyuki Y; Sato T; Fukuda A; Usui M; Tamura Y
    Jpn J Infect Dis; 2017 Jul; 70(4):461-463. PubMed ID: 28367887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High frequency of the exoU+/exoS+ genotype associated with multidrug-resistant "high-risk clones" of Pseudomonas aeruginosa clinical isolates from Peruvian hospitals.
    Horna G; Amaro C; Palacios A; Guerra H; Ruiz J
    Sci Rep; 2019 Jul; 9(1):10874. PubMed ID: 31350412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of Pseudomonas aeruginosa isolates from dogs and cats in Japan: current status of antimicrobial resistance and prevailing resistance mechanisms.
    Harada K; Arima S; Niina A; Kataoka Y; Takahashi T
    Microbiol Immunol; 2012 Feb; 56(2):123-7. PubMed ID: 22188523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective advantages of two major clones of carbapenem-resistant Pseudomonas aeruginosa isolates (CC235 and CC641) from Korea: antimicrobial resistance, virulence and biofilm-forming activity.
    Lee JY; Peck KR; Ko KS
    J Med Microbiol; 2013 Jul; 62(Pt 7):1015-1024. PubMed ID: 23558139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular characterization of
    Arfaoui A; Rojo-Bezares B; Fethi M; López M; Toledano P; Sayem N; Ben Khelifa Melki S; Ouzari HI; Klibi N; Sáenz Y
    J Med Microbiol; 2024 Jul; 73(7):. PubMed ID: 38963417
    [No Abstract]   [Full Text] [Related]  

  • 10. Difference of Type 3 secretion system (T3SS) effector gene genotypes (exoU and exoS) and its implication to antibiotics resistances in isolates of Pseudomonas aeruginosa from chronic otitis media.
    Park MH; Kim SY; Roh EY; Lee HS
    Auris Nasus Larynx; 2017 Jun; 44(3):258-265. PubMed ID: 27461174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clonal Distribution and Its Association With the Carbapenem Resistance Mechanisms of Carbapenem-Non-Susceptible
    Kim N; Ko SY; Park SY; Kim SY; Lee DE; Kwon KT; Kim YK; Lee JC
    Ann Lab Med; 2024 Sep; 44(5):410-417. PubMed ID: 38433574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutational inactivation of OprD in carbapenem-resistant Pseudomonas aeruginosa isolates from Korean hospitals.
    Kim CH; Kang HY; Kim BR; Jeon H; Lee YC; Lee SH; Lee JC
    J Microbiol; 2016 Jan; 54(1):44-49. PubMed ID: 26727901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interplay among Resistance Profiles, High-Risk Clones, and Virulence in the Caenorhabditis elegans Pseudomonas aeruginosa Infection Model.
    Sánchez-Diener I; Zamorano L; López-Causapé C; Cabot G; Mulet X; Peña C; Del Campo R; Cantón R; Doménech-Sánchez A; Martínez-Martínez L; Arcos SC; Navas A; Oliver A
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28923877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of loop-mediated isothermal amplification assays for genotyping of Type III Secretion System in Pseudomonas aeruginosa.
    Shi H; Chen Z; Kan J
    Lett Appl Microbiol; 2015 Oct; 61(4):361-6. PubMed ID: 26219625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular detection of type III secretory toxins in Pseudomonas aeruginosa isolates.
    Jarjees KK
    Cell Mol Biol (Noisy-le-grand); 2020 Jul; 66(5):9-14. PubMed ID: 33040805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coexistence of multidrug resistance mechanisms and virulence genes in carbapenem-resistant Pseudomonas aeruginosa strains from a tertiary care hospital in South India.
    Ellappan K; Belgode Narasimha H; Kumar S
    J Glob Antimicrob Resist; 2018 Mar; 12():37-43. PubMed ID: 28893647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterisation of VIM-2-producing Pseudomonas aeruginosa isolates from lower tract respiratory infections in a Spanish hospital.
    Bellés A; Bueno J; Rojo-Bezares B; Torres C; Javier Castillo F; Sáenz Y; Seral C
    Eur J Clin Microbiol Infect Dis; 2018 Oct; 37(10):1847-1856. PubMed ID: 29978304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacteraemia due to extensively drug-resistant Pseudomonas aeruginosa sequence type 235 high-risk clone: Facing the perfect storm.
    Recio R; Villa J; Viedma E; Orellana MÁ; Lora-Tamayo J; Chaves F
    Int J Antimicrob Agents; 2018 Aug; 52(2):172-179. PubMed ID: 29621591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emergence of GES-19-producing Pseudomonas aeruginosa exoU+ belonging to the global high-risk clone ST235 in cystic fibrosis infection.
    Rosales-Reyes R; Esposito F; Fontana H; Lezana-Fernández JL; Lascurain R; De la Cruz MA; Fuga B; Lincopan N; Santos-Preciado JI
    Diagn Microbiol Infect Dis; 2021 Sep; 101(1):115454. PubMed ID: 34271235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of Virulence Genes Associated with Type III Secretion System and Biofilm Formation in Pseudomonas aeruginosa Clinical Isolates.
    Ali ASBE; Ozler B; Baddal B
    Curr Microbiol; 2023 Oct; 80(12):389. PubMed ID: 37880467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.